| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2658d45a8e9c71b9598e2bf83242bab3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-739 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| filingDate |
2006-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11d0437be61c59da4c97ac37bf14f22b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3eb92f7799f8ce88be2e45f2ac83a047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fee9894d7f20bdcb023268c3ac873e2c |
| publicationDate |
2009-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009117089-A1 |
| titleOfInvention |
Glycolipids and analogues thereof as antigens for nk t cells |
| abstract |
This invention relates to immunogenic compounds which may serve as ligands for NKT (natural killer T) cells and to methods of use thereof in modulating immune responses. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011037859-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7928077-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010008954-A1 |
| priorityDate |
2005-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |